持續葡萄糖監測器，植入式，輔助使用
PMA 核准號：P160048 · 2026-03-19
廣告
器材摘要
Continuous glucose monitor, implanted, adjunctive use is the device name listed in this FDA 510(k) record. The listed applicant is Senseonics, Incorporated. It received FDA 510(k) clearance on 2026-03-19. The device is classified under product code QCD. It was reviewed by the CH advisory panel.
常見問題
What is the Continuous glucose monitor, implanted, adjunctive use?
Continuous glucose monitor, implanted, adjunctive use is a medical device that received FDA 510(k) clearance on 2026-03-19. The listed applicant is Senseonics, Incorporated.
When did Continuous glucose monitor, implanted, adjunctive use receive FDA 510(k) clearance?
The clearance date for Continuous glucose monitor, implanted, adjunctive use can be found in the official FDA records.
Who is the listed applicant for Continuous glucose monitor, implanted, adjunctive use?
The FDA 510(k) record lists Senseonics, Incorporated as the applicant. This does not by itself establish the device manufacturer.
What is the FDA product code for Continuous glucose monitor, implanted, adjunctive use?
The FDA product code for Continuous glucose monitor, implanted, adjunctive use is QCD.
相關臨床試驗
相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係，請查閱連結的官方來源。
官方來源
在 FDA 資料庫中查看 →資料來源為 FDA Open API。如需最新且權威的資訊，請始終參閱官方記錄。
廣告